![Lantern Pharma: Consider A Speculative Long-Term Investment In This AI Drug Discoverer | Seeking Alpha Lantern Pharma: Consider A Speculative Long-Term Investment In This AI Drug Discoverer | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215297032/image_1215297032.jpg?io=getty-c-crop-16-9)
Lantern Pharma: Consider A Speculative Long-Term Investment In This AI Drug Discoverer | Seeking Alpha
![Lantern Pharma Announces Closing of Public Offering of $69 Million USD and Full Exercise of Underwriter's Over-Allotment Option Lantern Pharma Announces Closing of Public Offering of $69 Million USD and Full Exercise of Underwriter's Over-Allotment Option](https://mma.prnewswire.com/media/1216507/Lantern_Pharma_Logo.jpg?p=facebook)
Lantern Pharma Announces Closing of Public Offering of $69 Million USD and Full Exercise of Underwriter's Over-Allotment Option
![Lantern Pharma Making Headway in Using AI to Revive Old Drugs, Develop New Compounds | Precision Oncology News Lantern Pharma Making Headway in Using AI to Revive Old Drugs, Develop New Compounds | Precision Oncology News](https://crain-platform-precisiononcologynews-prod.s3.amazonaws.com/s3fs-public/styles/800x600/public/adobestock_320302757.jpeg)
Lantern Pharma Making Headway in Using AI to Revive Old Drugs, Develop New Compounds | Precision Oncology News
![Follow the Money: Fossil Sells Smartwatch Tech to Google, Lantern Pharma Raises $535K, Alto Gets $14.5M » Dallas Innovates Follow the Money: Fossil Sells Smartwatch Tech to Google, Lantern Pharma Raises $535K, Alto Gets $14.5M » Dallas Innovates](https://s24806.pcdn.co/wp-content/uploads/2019/01/FollowTheMoney_Blankstock_istockphoto_target-with-dollar-line-icon-vector-id863865060.jpg)